None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Subject has provided written and dated informed consent to participate in the study. 2.Subject is willing and able to comply with the protocol. 3.Healthy male/female of age 18-60 years. 4.Subject is in good health as determined by a health history questionnaire.
Exclusion criteria
Exclusion criteria: 1.Subject has a known allergy or sensitivity to any ingredient in the test product. 2.Subject on protein and/ or probiotic rich diet. 3.Subject has a history of alcohol or other drug abuse in the past year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Primary outcome measure(s) will be change from baseline in Creatine Kinase and CRP Score (measured after exercise bout) at day 1, week 4 and week8. Timepoint: 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in the symptoms and signs of protein absorption and digestion, based on evaluation on Creatine Kinase and CRP and Pain VAS for muscle soreness, at the end of therapy.Timepoint: 8 weeks | — |
Countries
India
Contacts
Bioagile Therapeutics Pvt. Ltd